Technology
M&A Advisory
Pharmaceutical
M&A Advisory
Lazard
Full Credential Description
SciClone Pharmaceuticals. China, United States. Announced Date 19/04/2011. Closed Date 19/04/2011. Deal value: $105m. SciClone to acquire Novamed Pharmaceuticals. Industry: SciClone Pharmaceuticals operates in the biotechnology and pharmaceutical industry, focusing on developing and commercializing therapies for oncology, infectious diseases, and cardiovascular disorders.